Charles C. Clark
Nessuna posizione attualmente
Storia della carriera di Charles C. Clark
Precedenti posizioni note di Charles C. Clark
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Caremark Rx, Inc.
 Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Corporate Officer/Principal | - | 23/03/2007 |
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Settori
| Health Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Caremark Rx, Inc.
Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Health Services |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
- Borsa valori
- Insiders
- Charles C. Clark
- Esperienza
